Q3 2019 Tcm Group A/S Earnings Call Transcript
/-
Yes. Good morning, ladies and gentlemen. We have been looking forward to making presentation on our Q3 report for TCM.
And I will, together with our CFO, Mogens Elbrond Pedersen, comment on the business and financial results, after which we'll be handing over to the operator for a Q&A session.
So please turn to Page #2. Q3 was another strong quarter for TCM with a revenue growth of 17.3%, and this growth was entirely an organic growth. We are pleased to see that we continue to gain market share. Business-to-consumer is growing above market growth rates, and at the same time, business-to-business continued to have the highest growth rates. And we can see that our strategy of expanding across the business-to-business categories is successful.
Revenue for the quarter was DKK 238 million compared to DKK 202 million in Q3 last year. Adjusted EBITA increased by 19.9% to DKK 39 million, corresponding to an EBITA margin of 16.4%. This is slightly higher than the Q3 last year, which was at 16.1%. Our net working
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
